- জেনেরিক নাম
- Glipizide + Metformin Hydrochloride
- শক্তি
- 2.5 mg + 250 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Orion Pharma Ltd.
Metfozid Tablet
Metfozid 2.5 mg + 250 mg Tablet সম্পর্কে
বাংলাদেশে Metfozid 2.5 mg + 250 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Glipizide + Metformin Hydrochloride আছে (২.৫ mg + ২৫০ mg)। Glipizide + Metformin Hydrochloride-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এটি তৈরি করে Orion Pharma Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Glipizide + Metformin Hydrochloride-এর ৬টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Mefoglip 2.5 mg + 250 mg Tablet-এর, প্রতি ইউনিট ৳ ১.৯।
Metfozid 2.5 mg + 250 mg Tablet কী?
The tablet Metfozid contains Glipizide + Metformin Hydrochloride and is made by Orion Pharma Ltd. It is used under a doctor's supervision, and the dose is set by the doctor. That combines two oral diabetes medicines, Glipizide and Metformin Hydrochloride, in a strength of 2.5 mg + 250 mg. Use it only as your doctor directs.
Metfozid-এর ব্যবহার
It helps lower both fasting and post-meal blood sugar levels. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked. It can be started as initial therapy or used as second-line therapy when other treatments have not achieved satisfactory control. Your doctor will decide if it is suitable for you.
Metfozid কীভাবে ব্যবহার করবেন
The tablet is usually taken with meals, but the doctor will decide the dose and how often you take it. Swallow the tablet with water. Metfozid is taken by mouth. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.
Metfozid-এর পার্শ্বপ্রতিক্রিয়া
If you experience severe or persistent side effects, contact your doctor. Do not ignore symptoms that worry you. Common side effects include low blood sugar (hypoglycemia), diarrhea, nausea, vomiting, abdominal pain, headache, and muscle or joint pain. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
সতর্কতা ও নিরাপত্তা
It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. It is not recommended during pregnancy or breastfeeding. Older adults and those with reduced kidney function need careful dose adjustment. Tell your doctor about all your medical conditions and medicines before starting this tablet.
সাধারণ প্রশ্ন
What does Metfozid treat?
It helps lower both fasting and post-meal blood sugar levels. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked.
How is Metfozid used?
The tablet is usually taken with meals, but the doctor will decide the dose and how often you take it. Swallow the tablet with water.
What should I watch for while using Metfozid?
If you experience severe or persistent side effects, contact your doctor. Do not ignore symptoms that worry you.
Can I use Metfozid in pregnancy or while breastfeeding?
It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. It is not recommended during pregnancy or breastfeeding.
আরও পাওয়া যায়
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment ... Read moreGlipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment with a Sulfonylurea or Metformin do not result in adequate glycemic control in patients with type 2 diabetesফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Metformin is a biguanide antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacological mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylurea, metformin does not produce hypoglycemia in either patient with type 2 diabetes or normal subjects and does not cause hyperinsulinemia.Glipizide is a sulfonylurea which appears to lower blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glipizide & Metformin should be given once or twice daily with meals and should be initiated at a low dose, with gradual dose escalation.Glipizide & Metformin as Initial Therapy: The recommended starting dose is 250 mg/2.5 mg once a day with meal.
Glipizide & Metformin as Second-Line Therapy: The recommended starting dose is 500 mg/2.5 mg or 500 mg/5 mg twice daily with the morning and evening meals. The maximum recommended daily dose is 2000 mg Metformin/20 mg Glipizide.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Cimetidine reduces the renal clearance of Metformin. Alcohol potentiates the antihyperglycemic & hyperlactataemic effect of Metformin. It may enhance the effects of anti-coagulants. Such patients receiving the two drugs may need adjustment of the anti-coagulant dosage. Nifedipine appears to enhance the absorption of Metformin but Metformin has minimal effects on Nifedipine. The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to the drug, renal impairment, diabetic coma and ketoacidosis, chronic renal diseases, congestive heart failure, trauma, dehydration, alcohol dependence, pregnancy, breast-feeding etc.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Glipizide & Metformin are hypoglycemia,diarrhea, nausea/vomiting, abdominal pain, headache, musculoskeletal pain etc.
গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Contraindicated during Pregnancy & Lactationসতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Metformin is known to be substantially excreted by the kidney, and the risk of Metformin accumulation and lactic acidosis is increased with the degree of impairment of renal function. Thus, patients with serum creatinine levels above the upper limit of normal should not receive Metformin. In patients with advanced age, Metformin should be carefully titrated to establish minimum dose for adequate glycemic control, because aging is associated with reduced renal function. Metformin therapy should be temporarily suspended for any surgical procedure and should not be restarted until the patient’s oral intake has resumed and renal function has been evaluated as normal. During concomitant therapy with sulfonylurea, blood glucose should be monitored. Metformin & insulin therapy should be carried out in hospital until the correct ratio of the two drugs has been established. The metabolism and excretion of Glipizide may be slowed in patients with impaired renal and/or hepatic function. If hypoglycemia should occur in such patients, it may be prolonged and appropriate management should be instituted.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store below 25ºC in a cool and dry place.বিকল্প ব্র্যান্ড: Glipizide + Metformin Hydrochloride
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
Mefoglip Tablet
2.5 mg + 250 mg
Glipizide + Metformin Hydrochloride
Incepta Pharmaceuticals Ltd.
৳ ১.৮৬ ৳ ১.৯ ২% ছাড় প্রতি ইউনিট
Mefoglip Tablet
2.5 mg + 500 mg
Glipizide + Metformin Hydrochloride
Incepta Pharmaceuticals Ltd.
৳ ২.৭৪ ৳ ২.৮ ২% ছাড় প্রতি ইউনিট
Mefoglip Tablet
5 mg + 500 mg
Glipizide + Metformin Hydrochloride
Incepta Pharmaceuticals Ltd.
দাম দেওয়া নেই
Metfozid Tablet
2.5 mg + 500 mg
Glipizide + Metformin Hydrochloride
Orion Pharma Ltd.
দাম দেওয়া নেই
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।